News

At the heart of the deal is an anti-Claudin18.2 antibody-drug conjugate being developed for solid tumors, including gastric ...
Keros will be down to 85 full-time employees after the layoffs and expects to generate annualized savings of $17 million.
According to the nonprofit news outlet NOTUS, at least seven studies cited in the Make America Healthy Again report released ...
Patritumab deruxtecan was unable to significantly improve overall survival in patients with locally advanced or metastatic ...
While an adverse event reported in Intellia’s gene therapy trial was a “non-concern” for analysts, it follows a handful of ...
Looking for a biopharma job in New York? Check out the BioSpace list of seven companies hiring life sciences professionals ...
The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.
Teos expects to absorb nearly $25 million in one-time costs for severance and termination payments. The biotech had 173 ...
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...
It’s called the peak-end rule. People remember two things most about an experience: the most emotionally intense moment and ...
Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...
Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...